Finance

Lists
AFT:NZE
AFT Pharmaceuticals Ltd
NZ$4.38
+0.69%
(+0.030) 1D
Sep 3, 4:40:06 PM GMT+12  ·   NZD
All symbols
SymbolPriceChange% Change
Generating top insights for AFT...
Open
NZ$4.37
High
NZ$4.41
Low
NZ$4.36
Mkt. cap
462.50M
Avg. vol.
50.07K
Volume
36.56K
Dividend
0.57%
Quarterly dividend
NZ$0.01
Ex-dividend date
Jun 18, 2026
P/E ratio
31.18
52-wk high
NZ$4.85
52-wk low
NZ$2.56
EPS
NZ$0.14
Shares outstanding
104.87M
No. of employees
126
Open
NZ$4.37
High
NZ$4.41
Low
NZ$4.36
Mkt. cap
462.50M
Avg. vol.
50.07K
Volume
36.56K
Dividend
0.57%
Quarterly dividend
NZ$0.01
Ex-dividend date
Jun 18, 2026
P/E ratio
31.18
52-wk high
NZ$4.85
52-wk low
NZ$2.56
EPS
NZ$0.14
Shares outstanding
104.87M
No. of employees
126
About AFT Pharmaceuticals Ltd
CEOHartley Atkinson
Employees126
Founded1997
Headquarters-
SectorPharmaceutical industry
Websiteaftpharm.com
Previous reportsAll values in NZD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NZD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
57.47M
57.47M
69.88M
69.88M
Cost of goods sold
32.63M
32.63M
39.45M
39.45M
Cost of revenue
32.63M
32.63M
39.45M
39.45M
Research and development expenses
3.06M
3.06M
1.86M
1.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.10M
19.10M
18.83M
18.83M
Operating expense
22.48M
22.48M
20.58M
20.58M
Total operating expenses
55.10M
55.10M
60.03M
60.03M
Operating income
2.37M
2.37M
9.85M
9.85M
Other non operating income
462.50K
462.50K
-886.50K
-886.50K
EBT including unusual items
2.22M
2.22M
8.72M
8.72M
EBT excluding unusual items
2.22M
2.22M
8.72M
8.72M
Income tax expense
856.50K
856.50K
3.04M
3.04M
Effective tax rate
38.61%
38.61%
34.88%
34.88%
Other operating expenses
318.00K
318.00K
-113.00K
-113.00K
Net income
1.65M
1.65M
5.72M
5.72M
Net profit margin
2.87%
2.87%
8.18%
8.18%
Earnings per share
-
-
-
-
Interest and investment income
2.50K
2.50K
500.00
500.00
Interest expense
-615.00K
-615.00K
-628.00K
-628.00K
Net interest expenses
-612.50K
-612.50K
-627.50K
-627.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
3.07M
3.07M
11.00M
11.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps